Valion Bio (VBIO) FCF Margin Growth (1y) (2022 - 2025)
Valion Bio (VBIO) FCF Margin Growth (1y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.54 Bn | 2.84 Bn | -89.00 |
| 2 | Regeneron Pharmaceuticals | 86.13 Bn | 78.13 Bn | 3.93 Bn | -1,183.00 |
| 3 | Argenx Se | 65.58 Bn | 60.40 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | 26,102.00 |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn | 869.00 |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | 769.00 |
| 7 | BioNTech SE | 27.97 Bn | 9.58 Bn | 668.28 Mn | 4,109.00 |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 19,111.00 |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 811.00 |
| 10 | Valion Bio | 408,979.63 | -1.79 Mn | -45,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -252,736.00 |
| Sep 30, 2025 | -22,830.00 |
| Jun 30, 2025 | -119,802.00 |
| Mar 31, 2025 | -77,673.00 |
| Dec 31, 2024 | 12,839.00 |
| Sep 30, 2024 | -51,011.00 |
| Jun 30, 2024 | 65,655.00 |
| Mar 31, 2024 | 16,123.00 |
| Dec 31, 2023 | 3,659.00 |
| Sep 30, 2023 | -5,025.00 |
| Jun 30, 2023 | -122,958.00 |
| Mar 31, 2023 | -15,479.00 |
| Dec 31, 2022 | 16,564.00 |
| Sep 30, 2022 | 545.00 |
| Jun 30, 2022 | -11,936.00 |
| Mar 31, 2022 | -30,954.00 |